Saum Ghodoussipour

📢 The EA8212 “BRIDGE” study will officially close to accrual on July 24. If you have patients interested they will need to be randomized by then 👏 Huge thanks to all investigators—& especially patients—for helping enroll nearly 900 participants in just 2.5 years. @eaonc

Long-term follow-up report on salvage sequential intravesical Valrubicin and Docetaxel (Val/Doce) - High-Risk cohort (44% BCG-unresponsive, 96% Gem/Doce unresponsive, 20% prostatic urethral involvement) - 1y RFS 58% - 5y PFS 70% - 1% G3+ AEs Needs prospective eval! @eaonc

What a fantastic tool! Thanks for sharing. @KariTikkinen @GU_BigWhacks @saumyg @VigneshPackiam @UroAlsyouf @douglawi @LeileiXiaUro @alirezaghoreifi @domesypantsx3

New from the ROBUUST group in @Cancers_MDPI @FarshadSheybaee @Hoomandjaladat #UTUC #Immunotherapy 🔗Free link access: mdpi.com/2072-6694/17/1…

A very sad day learning that a giant in urology passed, Donald G. Skinner MD His impact was profound. His commitment to surgical excellence was only matched by his devotion to pt care and teaching. Simply the best mentor, colleague and friend RIP Boss @UroOnc @AmerUrological

🚨 NEW in #EuropeanUrology By @saumyg @UrogerliMD @spsutkaMD @tbivala1 @joanfundi et al Can novel intravesical therapies change the game for non–muscle-invasive bladder cancer? This systematic review explores: ✅ BCG-based combos ✅ Gene & immune therapies ✅ Innovative drug…

Awe-inspiring 1st week for our patients & our 💪🏼talented multi-disciplinary GU team at the Jack & Sheryl Morris Cancer Center @RutgersCancer @rwjurology #UroSoMe @SUO_YUO @UroOnc @NYSAUA #NewJersey's only @theNCI designated comprehensive #cancer center

Awesome, this can help us for debulking LG UTUC more to make Jelmyto more effective As well as our new trial for low volume HG UTUC clinicaltrials.gov/study/NCT06822…

A true honor to serve as VP @rwjurology. Incredible division led by empowering @TomJangUroOnc with star faculty @saumyg @VigneshPackiam @DGolombos @RoboUroMD @CChangUro Danielle Leitner. Excited for future of stunning new @RutgersCancer Center. Thx to all residents for…

🧬 Practice-changing insights👇 ctDNA role in high risk NMIBC ( T1HG and BCG unresponsive). First pub @CleClinicUro as we continue to learn more -- ctDNA is detectable in 35% of highest-risk NMIBC 💥 ctDNA+ often flags recurrence or upstaging ~3mo before imaging. In BCG-naïve:…

What a treat to host the inimitable @siadaneshmand @USC_Urology as our center's 2025 @rwjurology @RutgersCancer #Urology Visiting Prof! His journey & impact on our field incredibly inspiring #UroSoMe @NYSAUA @UroOnc @TestesCancer @BladderCancerUS @IBCG_BladderCA @AmerUrological

🚨BREAKING: The #FDA has approved mitomycin intravesical solution (Zusduri, formorly UGN-102) for the treatment of patients with recurrent low-grade intermediate-risk NMIBC. urologytimes.com/view/fda-appro…

Our take on radiation for NMIBC in @EUplatinum @saumyg @MelindaFu3 authors.elsevier.com/a/1lFCk14kpm0h…

Don't miss your chance to meet @RutgersCancer & @RWJBarnabas experts at #ASCO25! Visit booth #11025 to learn about advances in #CancerResearch and treatment and explore available positions at New Jersey’s only NCI-designated Comprehensive Cancer Center. @ASCO

🚨Exercise after #cancer diagnosis🚨 🏋️‍♀️🏋️‍♂️Ask any of my patients with cancer & you'll hear I always encourage fitness ✍️This new work in @JNCI_Now shows exercise after a new cancer diagnosis is associated with longer survival 👉This was true for patients with many GU cancers…

💡The best systematic reviews bring together a host of treatments in one paper for an easy reference 👏@saumyg et al. do that for #NMIBC strategies @EUplatinum 🔗shorturl.at/iKtml @UrogerliMD @spsutkaMD @MarkTysonMD @BladderCancerUS @GGiannarini

Excited to share this paper which has been many years in the making! This is the first publication of a predictive (AI-histology based) biomarker to guide rational use of BCG vs Gem/Doce for newly diagnosed HG NMIBC pubmed.ncbi.nlm.nih.gov/40287344/ Curves say it all 👇🏾

Honored to be recognized for driving innovation within our community-testament to hard work & dedication of my incredible team @RutgersCancer 🙏to @saumyg @VigneshPackiam @DGolombos @DrDaniVelez & leadership team supporting me @RichardalexMD @slibutti @DrAEvens #UroSoMe @NYSAUA

Congratulations to Dr. Saum Ghodoussipour @saumyg, Director of the Bladder & Urothelial Cancer Program at @RutgersCancer on receiving the 2025 SUO-CTC CG Oncology NMIBC Fellowship from the Society of Urologic Oncology Clinical Trials Consortium @UroOnc! ir.cgoncology.com/news-releases/…

So awesome to meet @JoepJdeJong at AUA after we have done a ton of work together remotely! I didn’t notice that I said BCG is the king.. like @JoshMeeks nice arguments @IBCG_BladderCA … for now! I am all for de-throning @urotoday @saumyg @RutgersCancer @IanMcelree